tirzepatide age approval 🚨 Diabetes News Update for Families 🚨 Big update in pediatric diabetes care 👇 Mounjaro (tirzepatide) is now approved for children and adolescents ages 10 and older with type 2 diabetes. This Mounjaro Injection for Weight Loss

Continue at 2.4mg indefinitely

Injection-site reactions are more likely if the same area is used repeatedly or if the injection is given into irritated skin

The reduced caloric deficit (300-500 calories versus 800 calories with higher doses) results in more gradual but sustainable weight management

A method for treating type 2 diabetes in a subject in need thereof, wherein the subject in need of treatment is pediatric

Studies have demonstrated oral semaglutide to be cost-effective versus both injectable GLP-1RAs and some oral agents

Propionyl-L-Carnitine This ones used more in medical settings, like for people with circulation issues